Biblio

Export 768 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2019
J. M. J. Vonk, Rentería, M. Arce, Medina, V. M., Pericak-Vance, M. A., Byrd, G. S., Haines, J., Brickman, A. M., and Manly, J. J., Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults., J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
N. Sakae, Heckman, M. G., Vargas, E. R., Carrasquillo, M. M., Murray, M. E., Kasanuki, K., Ertekin-Taner, N., Younkin, S. G., and Dickson, D. W., Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures., J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
K. Deckers, Nooyens, A., van Boxtel, M., Verhey, F., Verschuren, M., and Köhler, S., Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study., J Alzheimers Dis, vol. 70, no. s1, pp. S31-S41, 2019.
K. Deckers, Nooyens, A., van Boxtel, M., Verhey, F., Verschuren, M., and Köhler, S., Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study., J Alzheimers Dis, vol. 70, no. s1, pp. S31-S41, 2019.
K. Deckers, Nooyens, A., van Boxtel, M., Verhey, F., Verschuren, M., and Köhler, S., Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study., J Alzheimers Dis, vol. 70, no. s1, pp. S31-S41, 2019.
P. Oeckl, Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., Lewczuk, P., Danek, A., Ludolph, A. C., and Otto, M., Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment., J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
A. Amlie-Wolf, Tang, M., Way, J., Dombroski, B., Jiang, M., Vrettos, N., Chou, Y. - F., Zhao, Y., Kuzma, A., Mlynarski, E. E., Leung, Y. Yee, Brown, C. D., San Wang, L. -, and Schellenberg, G. D., Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants., J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
A. L. La, Walsh, C. M., Neylan, T. C., Vossel, K. A., Yaffe, K., Krystal, A. D., Miller, B. L., and Karageorgiou, E., Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers., J Alzheimers Dis, vol. 67, no. 3, pp. 911-921, 2019.
M. Heffernan, Andrews, G., Singh, M. A. Fiataron, Valenzuela, M., Anstey, K. J., Maeder, A. J., McNeil, J., Jorm, L., Lautenschlager, N. T., Sachdev, P. S., Ginige, J. A., Hobbs, M. J., Boulamatsis, C., Chau, T., Cobiac, L., Cox, K. L., Daniel, K., Flood, V. M., Guerrero, Y., Gunn, J., Jain, N., Kochan, N. A., Lampit, A., Mavros, Y., Meiklejohn, J., Noble, Y., O'Leary, F., Radd-Vagenas, S., Walton, C. C., and Brodaty, H., Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds., J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
M. D. van der Hoek, Nieuwenhuizen, A., Keijer, J., and J Ashford, W., The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment., J Alzheimers Dis, vol. 67, no. 3, pp. 1045-1054, 2019.
S. Toppala, Ekblad, L. L., Lötjönen, J., Helin, S., Hurme, S., Johansson, J., Jula, A., Karrasch, M., Koikkalainen, J., Laine, H., Parkkola, R., Viitanen, M., and Rinne, J. O., Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions., J Alzheimers Dis, vol. 72, no. 1, pp. 215-228, 2019.
L. Calderón-Garcidueñas, Mukherjee, P. S., Kulesza, R. J., Torres-Jardón, R., Hernández-Luna, J., Ávila-Cervantes, R., Macías-Escobedo, E., González-González, O., González-Maciel, A., García-Hernández, K., Hernández-Castillo, A., and Villarreal-Ríos, R., Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites., J Alzheimers Dis, vol. 68, no. 3, pp. 1113-1123, 2019.
J. Brandt, Buchholz, A., Henry-Barron, B., Vizthum, D., Avramopoulos, D., and Cervenka, M. C., Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease., J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
B. Gyanwali, Shaik, M. Amin, Tan, B. Yeow, Venketasubramanian, N., Chen, C., and Hilal, S., Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population., J Alzheimers Dis, vol. 67, no. 4, pp. 1209-1219, 2019.
L. Vaskivuo, Hokkanen, L., Hänninen, T., Antikainen, R., Bäckman, L., Laatikainen, T., Paajanen, T., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Ngandu, T., Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change., J Alzheimers Dis, vol. 71, no. 3, pp. 785-795, 2019.
C. - Di Chen, Zeldich, E., Khodr, C., Camara, K., Tung, T. Yu, Lauder, E. C., Mullen, P., Polanco, T. J., Liu, Y. - Y., Zeldich, D., Xia, W., Van Nostrand, W. E., Brown, L. E., Porco, J. A., and Abraham, C. R., Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling., J Alzheimers Dis, vol. 67, no. 3, pp. 1089-1106, 2019.
K. Heser, Kleineidam, L., Wiese, B., Oey, A., Roehr, S., Pabst, A., Kaduszkiewicz, H., van den Bussche, H., Brettschneider, C., König, H. - H., Weyerer, S., Werle, J., Fuchs, A., Pentzek, M., Mösch, E., Bickel, H., Maier, W., Scherer, M., Riedel-Heller, S. G., and Wagner, M., Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men., J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
L. Fani, Hilal, S., Sedaghat, S., Broer, L., Licher, S., Arp, P. P., van Meurs, J. B. J., M Ikram, K., and M Ikram, A., Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study., J Alzheimers Dis, vol. 73, no. 2, pp. 707-714, 2019.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
C. DeCarli, Villeneuve, S., Maillard, P., Harvey, D., Singh, B., Carmichael, O., Fletcher, E., Olichney, J., Farias, S., Jagust, W., Reed, B., and Mungas, D., Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury., J Alzheimers Dis, vol. 68, no. 1, pp. 187-196, 2019.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.

Pages